MetaCap

Unicycive Therapeutics Inc. (UNCY)

NASDAQ: UNCYHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.06-0.125 (-2.99%)

Market open · Delayed 15 min · as of Oct 8, 11:07 AM ET

UNCY stock chart

Technical analysis

Key statistics

All statistics
Market cap
$111.08M
EPS (TTM)
-$1.72
52-week range
3.93 – 8.74
Day range
4.03 – 4.20
Volume / Avg
328.31K / 837.51K
Beta
—
Next earnings
Nov 12, 2026

52-week range

$3.93$8.74

UNCY stock today

Shares of Unicycive Therapeutics (UNCY) are trading lower on Oct 8 at $4.06, a drop of 2.99% or $0.125 per share, versus the S&P 500's 0.27% decline. Shares are 53.6% below their 52-week high of $8.74, set on May 14, 2026 and 3.2% above the 52-week low of $3.93, near the bottom of the past year's range. UNCY is down 27.6% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 9.7%.

Unicycive Therapeutics has posted a net loss over the last twelve months (EPS of -$1.72), so its P/E ratio is not meaningful. Unicycive Therapeutics's next earnings report is expected on Nov 12, 2026.

Summary generated from market data by MetaCap's automated system. Methodology

About Unicycive Therapeutics

Company profile
Industry
Biotechnology: Pharmaceutical Preparations
IPO year
2021

Earnings

Earnings history
Next report
Nov 12, 2026

UNCY news

All UNCY news

Unicycive Therapeutics peers

Health Care sector
UNCY peer companies
CompanyPrice% ChgMarket capCompare
FHTXFoghorn Therapeutics Inc.1.93-7.66%$114.61Mvs UNCY
INOInovio Pharmaceuticals Inc.1.11-3.90%$114.77Mvs UNCY
COYACoya Therapeutics Inc.4.84-1.43%$113.53Mvs UNCY
PMVPPMV Pharmaceuticals Inc.1.53+2.00%$115.53Mvs UNCY
RANIRani Therapeutics Holdings Inc. Class A0.7975-1.80%$112.06Mvs UNCY
GNLXGenelux Corporation2.46-2.38%$111.30Mvs UNCY
SDEVStablecoin Development Corporation2.12-23.92%$109.45Mvs UNCY
VTVTvTv Therapeutics Inc. Class A30.34-2.16%$119.96Mvs UNCY

Indexes, lists and sector

Unicycive Therapeutics stock FAQ

What is Unicycive Therapeutics's stock price today?

UNCY last traded at $4.06 as of Oct 8, 11:07 AM EDT, down 2.99% on the day. Prices are delayed at least 15 minutes.

Does Unicycive Therapeutics pay a dividend?

No. Unicycive Therapeutics does not currently pay a regular cash dividend.

When is Unicycive Therapeutics's next earnings date?

Unicycive Therapeutics is expected to report earnings on Thursday, November 12, 2026.

Has UNCY ever split its stock?

Yes. The most recent UNCY stock split was a 1-for-10 split on Jun 20, 2025.

What is the UNCY 52-week high?

The 52-week high for UNCY is $8.74 and the 52-week low is $3.93. The stock is currently 53.6% below its high.

Compare UNCY